Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

G1 Therapeutics Q2 2024 GAAP EPS $(0.10) Beats $(0.17) Estimate, Sales $16.546M Beat $16.363M Estimate

Author: Benzinga Newsdesk | August 08, 2024 06:33am
G1 Therapeutics (NASDAQ:GTHX) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of $(0.17) by 41.18 percent. This is a 171.43 percent decrease over earnings of $0.14 per share from the same period last year. The company reported quarterly sales of $16.546 million which beat the analyst consensus estimate of $16.363 million by 1.12 percent. This is a 60.97 percent decrease over sales of $42.392 million the same period last year.

Posted In: GTHX


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist